Effects of antiepileptic drug substitutions on epileptic events requiring acute care

Pharmacotherapy

Volumn 29, Issue 7, 2009, Pages 769-774

  Rascati, Karen L ^a   Richards, Kristin M ^a   Johnsrud, Michael T ^a   Mann, Teresa A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antiepileptic drug; Drug switching; Epilepsy; Generic substitution; Narrow therapeutic index

Indexed keywords

ANTICONVULSIVE AGENT; GENERIC DRUG;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG SUBSTITUTION; EMERGENCY CARE; EMERGENCY WARD; EPILEPSY; FEMALE; HOSPITALIZATION; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT CODING; SEIZURE; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CASE-CONTROL STUDIES; CHILD; DATABASES, FACTUAL; DRUGS, GENERIC; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; EPILEPSY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; THERAPEUTIC EQUIVALENCY; UNITED STATES; YOUNG ADULT;

EID: 67650831241     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.7.769     Document Type: Article

References (12)

1. Crawford P, Hall WW, Chappell B, Collings J, Stewart A. Generic prescribing for epilepsy: is it safe? Seizure 1996;5:1-5.
2. Besag FM. Is generic prescribing acceptable in epilepsy? Drug Saf 2000;23:173-82
3. Berg M. What's the problem with generic antiepileptic drugs? A call to action. Neurology 2007;68:1245-1246 (Pubitemid 46625966)
4. Center for Drug Evaluation and Research, U.S. Food and Drug Administration. Approved drug products with therapeutic equivalence evaluations, 28th ed. Washington, DC: U.S. Department of Health and Human Services, 2008.
5. Kirking DM, Ascione FJ. Perspectives on generic pharmaceuticals: some conclusions. J Am Pharm Assoc (Wash) 2001;41:826-8
6. Wilner AN. Therapeutic equivalency of generic antiepileptic drugs: results of a survey. Epilepsy Behav 2004;5:995-998 (Pubitemid 40003924)
7. Haskins LS, Tomaszewski KJ, Crawford P. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy. Epilepsy Behav 2005;7:98-105. (Pubitemid 40975284)
8. Kramer G, Steinhoff BJ, Feucht M, Pfafflin M, May TW. Experience with generic drugs in epilepsy patients: an electronic survey of members of the German, Austrian and Swiss branches of the ILAE. Epilepsia 2007;48:609-611 (Pubitemid 46365177)
9. Berg MJ, Gross RA, Tomaszewski KJ, Zingaro WM, Haskins LS. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures. Neurology 2008;71:525-30
10. Liow K, Barkley GL, Pollard JR, Harden CL, Bazil CW. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy. Neurology 2007;68:1249-1250 (Pubitemid 46625968)
11. Epilepsy Foundation. Health care reform: statement on substitution of generic antiepileptic drugs. June 1996. Available from www.epilepsyfoundation. org/advocacy/care/genedrev.cfm. Accessed August 28, 2008.
12. Zachry WM 3rd, Doan QD, Clewell JD, Smith BJ. Casecontrol analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes. Epilepsia 2009;50(3):493-500.